Enhancement of Morphine-withdrawal and Apomorphine-induced Aggression by Clonidine

Overview

Journal Psychopharmacol Commun

Specialty Pharmacology

Date 1976 Jan 1

PMID 988609

Citations 12

Authors

G Gianutsos

M D Hynes

H Lal

Affiliations

Soon will be listed here.

Abstract

Clonidine, a proposed alpha-noradrenergic receptor stimulant, intensifies the aggression occuring during morphine-withdrawal or following the administration of apomorphine. The possibility of a noradrenergic/dopaminergic interaction in drug-induced aggression is discussed.

Citing Articles

Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options.

Corley C, Craig A, Sadek S, Marusich J, Chehimi S, White A Pharmacol Biochem Behav. 2024; 243():173836.

PMID: 39067531 PMC: 11344688. DOI: 10.1016/j.pbb.2024.173836.

Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence.

Dunn K, Huhn A, Bergeria C, Gipson C, Weerts E J Pharmacol Exp Ther. 2019; 371(2):422-452.

PMID: 31391211 PMC: 6863456. DOI: 10.1124/jpet.119.258004.

The role of mesocorticolimbic dopamine in regulating interactions between drugs of abuse and social behavior.

Young K, Gobrogge K, Wang Z Neurosci Biobehav Rev. 2010; 35(3):498-515.

PMID: 20600286 PMC: 3578706. DOI: 10.1016/j.neubiorev.2010.06.004.

Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: suppression by alpha 2-adrenoceptor stimulation.

van der Laan J, Weick G, Hillen F Psychopharmacology (Berl). 1983; 81(3):267-71.

PMID: 6139840 DOI: 10.1007/BF00427276.

Social, motor, and autonomic signs of morphine withdrawal: differential sensitivities to catecholaminergic drugs in mice.

Kantak K, Miczek K Psychopharmacology (Berl). 1988; 96(4):468-76.

PMID: 3149768 DOI: 10.1007/BF02180026.